Developed by EU Pfizer, etc. Agreed to purchase 300 million new coronaviruses November 12, 5:05
The EU-European Union has agreed to purchase up to 300 million doses of the new coronavirus vaccine developed by American pharmaceutical giant Pfizer and others.
Pfizer, a major American pharmaceutical company, announced on the 9th the preliminary results of a clinical trial that the vaccine being developed with the German company "Biontech" has "more than 90% preventive effect".
The European Commission, the EU's executive body, announced on the 11th that it has signed a contract to purchase up to 300 million doses of this vaccine.
On behalf of EU member states, they will first purchase 200 million doses and then purchase up to 100 million additional doses as needed.
This is the fourth time the EU has signed a vaccine purchase contract, following British pharmaceutical giant AstraZeneca.
"Once approved for use, we will approach a sustainable solution to the spread of the infection," said Von der Leyen, chairman of the European Commission.
Regarding the outlook for vaccine supply, Pfizer says it will be able to produce 50 million doses by the end of the year and up to 1.3 billion doses next year, and the Japanese government has basically agreed to receive supply for 60 million people by the end of June next year. I will.